쎌바이오텍 분기보고서 (2016.09)
1. 요약재무정보

가. 요약연결재무정보

구 분	제 22기 3분기	제 21기	제 20기

(2016년9월말)	(2015년12월말)	(2014년12월말)

[유동자산]	63,070,041,457	54,150,513,012	38,800,498,113

·현금및현금성자산	10,495,597,894	7,272,875,829	5,385,808,119

·매출채권및기타유동채권	8,808,862,016	9,311,574,554	8,354,572,007

·금융상품자산	40,486,590,000	34,606,184,587	22,138,811,666

·단기투자자산	121,551,930	-	308,852,595

·재고자산	2,325,356,123	2,521,478,081	1,985,857,841

·기타유동자산	832,083,494	437,762,564	623,551,685

·당기법인세자산	-	637,397	3,044,200

[비유동자산]	21,427,825,600	20,817,336,026	18,803,634,418

·장기매출채권및기타비유동채권	340,995,593	264,874,621	226,520,721

·금융상품자산	505,000,000	505,000,000	506,000,000

·장기투자자산	241,738,751	287,043,173	488,062,169

·유형자산	19,369,085,305	18,780,486,861	16,769,895,823

·무형자산	830,672,341	843,148,796	679,982,615

·이연법인세자산	140,333,610	136,782,575	133,173,090

자 산 총 계	84,497,867,057	74,967,849,038	57,604,132,531

[유동부채]	5,459,034,376	6,163,135,072	5,206,116,240

[비유동부채]	15,476,000	47,462,020	37,462,020

부 채 총 계	5,474,510,376	6,210,597,092	5,243,578,260

[지배기업 소유주지분]	79,023,356,682	68,757,251,946	52,360,554,271

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	39,383,612	48,368,033	(1,189,378)

[이익잉여금]	66,784,645,421	56,509,556,264	40,162,416,000

[비지배지분]	-	-	-

자 본 총 계	79,023,356,682	68,757,251,946	52,360,554,271

기 간	(2,016.01.01~	(2015.01.01~	(2014.01.01~

2,016.09.30)	2015.12.31)	2014.12.31)

매출액	43,131,322,857	49,504,515,603	40,767,743,986

영업이익	16,979,895,263	18,758,807,947	12,905,528,179

당기순이익	13,363,089,157	17,505,140,264	10,402,695,484

지배기업 소유주지분	13,363,089,157	17,505,140,264	10,402,695,484

비지배지분	-	-	-

주당순이익	1,731	2,268	1,347

연결에포함된회사수	3	3	3

나.요약별도재무정보

구 분	제 22기 3분기	제 21기	제 20기

(2016년9월말)	(2015년12월말)	(2014년12월말)

[유동자산]	61,727,372,181	53,860,925,500	38,348,055,313

·현금및현금성자산	9,039,159,779	6,822,021,385	4,924,776,918

·매출채권및기타유동채권	9,986,035,453	10,418,352,866	9,337,826,816

·금융상품자산	39,586,590,000	33,706,184,587	21,238,811,666

·단기투자자산	121,551,930	-	308,852,595

·재고자산	2,286,424,656	2,488,101,480	1,936,220,896

·기타유동자산	707,610,363	426,265,182	601,566,422

[비유동자산]	23,920,640,065	22,233,829,427	20,442,417,308

·장기매출채권및기타비유동채권	37,850,411	8,850,411	8,850,411

·금융상품자산	505,000,000	505,000,000	506,000,000

·장기투자자산	151,017,861	224,009,929	461,164,833

·종속기업투자주식	3,218,445,020	2,118,819,740	2,065,845,531

·유형자산	19,233,821,177	18,616,137,994	16,701,018,122

·무형자산	703,851,728	689,416,428	644,222,381

·이연법인세자산	70,653,868	71,594,925	55,316,030

자 산 총 계	85,648,012,246	76,094,754,927	58,790,472,621

[유동부채]	4,770,942,402	5,415,695,302	4,263,932,125

[비유동부채]	20,476,000	47,677,600	37,677,600

부 채 총 계	4,791,418,402	5,463,372,902	4,301,609,725

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	37,592	(3,298,882)	26,926,508

[이익잉여금]	68,657,228,604	58,435,353,258	42,262,608,739

자 본 총 계	80,856,593,845	70,631,382,025	54,488,862,896

종속ㆍ관계ㆍ공동기업 투자주식의 평가방법	원가법	원가법	원가법

기 간	(2016.01.01~	(2015.01.01~	(2014.01.01~

2016.09.30)	2015.12.31)	2014.12.31)

매출액	41,856,595,503	49,024,773,708	40,461,684,447

영업이익	16,888,810,773	19,214,527,103	14,616,719,951

당기순이익	13,309,875,346	17,330,744,519	12,034,346,815

주당순이익	1,724	2,245	1,559